Skip to main content
. 2024 Sep 6;13(17):5285. doi: 10.3390/jcm13175285

Table 1.

Demographic data.

Age, mean (SD), y 12.1 (3.9)
Body mass, mean (SD), kg 44.9 (18.0)
Height, mean (SD), cm 149.8 (21.7)
Sex, female, n (%) 22 (44%)
Ambulatory status, ambulatory, n (%) 34 (68%)
MRC knee extensors, n 36
  MRC 3, n (%) 11 (31%)
  MRC ≥ 4, n (%) 25 (69%)
MRC knee flexors, n 37
  MRC 3, n (%) 5 (14%)
  MRC ≥ 4, n (%) 32 (86%)
MRC elbow extensors, n 40
  MRC 3, n (%) 5 (12.5%)
  MRC ≥ 4, n (%) 35 (87.5%)
MRC elbow flexors, n 49
  MRC 3, n (%) 14 (29%)
  MRC ≥ 4, n (%) 35 (71%)
Diagnosis, n (%)
  Axonal motor neuropathy 1 (2%)
  Axonal polyneuropathy 1 (2%)
  Becker muscular dystrophy 3 (6%)
  Carey Fineman Ziter syndrome 2 (4%)
  Central core myopathy 1 (2%)
  Duchenne muscular dystrophy 1 (2%)
  Hereditary motor and sensory neuropathy 7 (14%)
  Myotonic dystrophy 1 (2%)
  Myasthenia gravis 2 (4%)
  Myotonica congenita (type Becker) 2 (4%)
  Nemaline myopathy 1 (2%)
  Silver syndrome 1 (2%)
  Spinal muscular atrophy 27 (54%)
    1c 1 (2%)
    2a 7 (14%)
    2b 1 (2%)
    3a 17 (34%)
    3b 1 (2%)

MRC (Medical Research Council) scale.